Tapas D, Sharmila B. Theranostic applications of Lutetium-177 in radionuclide therapy. Curr Radiopharm. 2016;9:94–101.

Google Scholar 

Filippi L, Chiaravalloti A, Schillaci O, Cianni R, Bagni O. Theranostic approaches in nuclear medicine: current status and future prospects. Expert Rev Med Devices. 2020;17:331–43.

Article  CAS  PubMed  Google Scholar 

Al-Ibraheem A, Mohamedkhair A. Current status of theranostics in Jordan. Nucl Med Mol Imaging. 2019;53:7–10.

Article  CAS  PubMed  Google Scholar 

Al-Ibraheem A, Scott AM, Abdlkadir AS, Vrachimis A, Lamoureux F, Trujillo PB, et al. Consensus nomenclature for radionuclide therapy: initial recommendations from nuclear medicine global initiative. J Nucl Med. 2025;66:757.

Article  PubMed  Google Scholar 

Habib SH, Saha S. Burden of non-communicable disease: global overview. Diabetes Metab Syndr. 2010;4(1):41–7.

Article  Google Scholar 

Al-Ibraheem A, Zimmermann R, Abdlkadir AS, Herrmann K. Radiotheranostics global market and future developments. Semin Nucl Med. 2024;54:622–33.

Article  PubMed  Google Scholar 

Marzo RR, Bhattacharya S, Aye SS, Tripathi S, Naing TW, Soe MM, et al. Study on the quality of life among cancer survivors attending a tertiary care cancer center in Malaysia. J Public Health Res. 2022;11:2563.

Google Scholar 

Ministry of Health Malaysia. National Strategic Plan for Cancer Control Programme 2021–2025. 2021.https://www.moh.gov.my/moh/resources/Penerbitan/Rujukan/NCD/National_Strategic_Plan_for_Cancer_Control_Programme_2021-2025.pdf. Accessed 13 December 2024.

Al-Ibraheem A, Abdlkadir AS, Albalooshi B, Alkuwari M, Al Mahariq D, Al-Nabhani K, et al. Current status of theranostics in West asia: a country-based surveillance study. Nucl Med Mol Imaging. 2025;69:622–33.

Google Scholar 

Lin KH, Chen YW, Lee RC, Wang LW, Chou FI, Chang CW, et al. Nuclear theranostics in Taiwan. Nucl Med Mol Imaging. 2019;53:86–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadgar H, Norouzbeigi N, Assadi M, Jafari E, Al-Balooshi B, Al-Ibraheem A, et al. A prospective evaluation of chemokine receptor-4 (CXCR4) overexpression in high-grade glioma using ⁶⁸Ga-Pentixafor (Pars-Cixafor™) PET/CT imaging. Acad Radiol. 2025;32:2247–56.

Article  PubMed  Google Scholar 

Yang W, Kang F, Chen Y, Zhu Z, Wang F, Qin C, et al. Landscape of nuclear medicine in China and its progress on theranostics. J Nucl Med. 2024;65:S29–37.

Article  Google Scholar 

Duan H, Iagaru A, Aparici CM. Radiotheranostics – precision medicine in nuclear medicine and molecular imaging. Nanotheranostics. 2022;6:103–17.

Article  PubMed  PubMed Central  Google Scholar 

International Atomic Energy Agency. Technical meeting on commercial products and services of research reactors- applications and services at PUSPATI TRIGA reactor in malaysia: current status and outlook. Vienna: IAEA; 2011.

Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, et al. A review of theranostics: perspectives on emerging approaches and clinical advancements. Radiol Imaging Cancer. 2023;5:220157.

Article  Google Scholar 

Hasan S, Prelas MA. Molybdenum-99 production pathways and the sorbents for ⁹⁹Mo/⁹⁹Tc generator systems using (n, γ) ⁹⁹Mo: a review. SN Appl Sci. 2020;2:1782.

Article  CAS  Google Scholar 

Dash A, Pillai MR, Knapp FF Jr. Production of ¹⁷⁷Lu for targeted radionuclide therapy: available options. Nucl Med Mol Imaging. 2015;49:85–107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fadzil MFA, Hasan S, Janib SNM, Kasbollah A, Wafa SAF. A survey on the usage and demand of medical radioisotope & radiopharmaceuticals in Malaysia. J Nucl Relat Technol. 2015;12:40–55.

Google Scholar 

Ashhar Z, Ahmad Fadzil MF, Hassan H, Othman MF, Md Hassan MB, Chun Vui VY, et al. The potential of radiolabeled bisphosphonates in SPECT and PET for bone imaging. Curr Med Imaging. 2024;20:e15734056270935.

Article  PubMed  Google Scholar 

Ashhar Z, Ahmad Fadzil MF, Md Safee Z, Aziz F, Ibarhim UH, Nik Afinde NMF, et al. Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron. Appl Radiat Isot. 2024;205:111161.

Article  CAS  PubMed  Google Scholar 

Ashhar Z, Ahmad Fadzil MF, Othman MF, Yusof NA, Abdul Onny MA, Mat Ail N, et al. Cyclotron production of Gallium-68 radiopharmaceuticals using the ⁶⁸Zn(p,n)⁶⁸Ga reaction and their regulatory aspects. Pharmaceutics. 2023;15:70.

Article  CAS  Google Scholar 

Hendrikse H, Kiss O, Kunikowska J, Wadsak W, Decristoforo C, Patt M. EANM position on the in-house preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2022;49:1095–8.

Article  PubMed  Google Scholar 

Said MA, Masud MA, Zaini MZ, Salleh RA, Lee BN, Zainon R. Lu-177 DOTATATE dosimetry for neuroendocrine tumor: single center experience. J Phys Conf Ser. 2017;851:012017.

Article  Google Scholar 

Albert R, Smith-Jones P, Stolz B, Simeon C, Knecht H, Bruns C, et al. Direct synthesis of [DOTA-DPhe¹]-octreotide and [DOTA-DPhe¹, Tyr³]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorg Med Chem Lett. 1998;8:1207–10.

Article  CAS  PubMed  Google Scholar 

Kubíček V, Havlíčková J, Kotek J, Tircsó G, Hermann P, Tóth É, et al. Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. Inorg Chem. 2010;49:10960–9.

Article  PubMed  Google Scholar 

Breeman WAP, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP. Radiolabelling DOTA-peptides with ⁶⁸Ga. Eur J Nucl Med Mol Imaging. 2005;32:478–85.

Article  CAS  PubMed  Google Scholar 

Baum RP, Kulkarni HR. Theranostics: from molecular imaging using ⁶⁸Ga-labeled tracers and PET/CT to personalized radionuclide therapy – the bad Berka experience. Theranostics. 2012;2:437–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Werner RA, Bluemel C, Allen-Auerbach MS, Higuchi T, Herrmann K. ⁶⁸Gallium- and ⁹⁰Yttrium-/¹⁷⁷Lutetium: theranostic twins for diagnosis and treatment of NETs. Ann Nucl Med. 2015;29:1–7.

Article  CAS  PubMed  Google Scholar 

Kumar K, Chang CA, Francesconi LC, Dischino DD, Malley MF, Gougoutas JZ, et al. Synthesis, stability, and structure of gadolinium(III) and yttrium(III) macrocyclic poly(amino carboxylates). Inorg Chem. 1994;33:3567–75.

Article  CAS  Google Scholar 

Viola-Villegas N, Doyle RP. The coordination chemistry of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid (H₄DOTA): structural overview and analyses on structure–stability relationships. Coord Chem Rev. 2009;253:1906–25.

Article  CAS  Google Scholar 

Loncin MF, Desreux JF, Merciny E. Coordination of lanthanides by two polyamino polycarboxylic macrocycles: formation of highly stable lanthanide complexes. Inorg Chem. 1986;25:2646–8.

Article  CAS  Google Scholar 

Clarke ET, Martell AE. Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles. Inorg Chim Acta. 1991;190:37–46.

Article  CAS  Google Scholar 

Eder M, Wängler B, Knackmuss S, LeGall F, Little M, Haberkorn U, et al. Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for ⁶⁸Ga-labeled small Recombinant antibodies. Eur J Nucl Med Mol Imaging. 2008;35:1878–86.

Article  CAS  PubMed  Google Scholar 

Eder M, Schäfer M, Bauder-Wüst U, Hull WE, Wängler C, Mier W, et al. ⁶⁸Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem. 2012;23:688–97.

Article  CAS  PubMed  Google Scholar 

Kularatne SA, Zhou Z, Yang J, Post CB, Low PS. Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted ⁹⁹Tc-radioimaging agents. Mol Pharm. 2009;6:790–800.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Price EW, Orvig C. Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev. 2014;43:260–90.

Article  CAS  PubMed  Google Scholar 

Taliaferro CH, Martell A. New multidentate ligands. XXIV. Disodium-N,N′-bis(2-h